Efficacy and safety of cyclosporine a microemulsion in maintenance patients with chronic plaque psoriasis

Journal of Drugs in Dermatology, Jan, 2008

Sponsored by Novartis. The study will evaluate the efficacy of cyclosporine when administered twice a week compared to continuous administration, in patients with chronic plaque psoriasis.

Condition                 Intervention          Phase

Chronic Plaque Psoriasis  Drug: Cyclosporine A  Phase III
                            microemulsion

Study ID Numbers: COLO400CIT04

ClinicalTrials.gov Identifier: NCT00438360